Shanghai, China

Xiaohui Shao

USPTO Granted Patents = 2 

Average Co-Inventor Count = 14.9

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):

Title: The Innovative Mind of Xiaohui Shao

Introduction

Xiaohui Shao, an accomplished inventor based in Shanghai, China, has made significant contributions in the field of immunology through his innovative patents. With a total of two patents, Shao has demonstrated his expertise and commitment to advancing medical science, particularly in cancer treatment.

Latest Patents

Shao's latest patents highlight his cutting-edge research and ingenuity. The first patent, titled "SEMA4D antibody, preparation method therefor and use thereof," introduces a murine or fully human monoclonal antibody that specifically targets SEMA4D. This antibody is designed to bind to the SEMA4D antigen, showcasing activities aimed at combating tumors. The second patent, "Anti-human LAG-3 monoclonal antibody and use thereof," presents a novel monoclonal antibody that targets LAG-3, along with a preparation method. This innovative antibody not only binds to LAG-3 antigens with high specificity but also exhibits impressive anti-tumor activity, marking a significant advancement in targeted therapies.

Career Highlights

Shao works at Jiangsu Huaiyu Pharmaceutical Co., Ltd., where he applies his expertise in developing groundbreaking pharmaceuticals. His dedication to research and innovation has positioned him as a leading figure in his field, contributing to important advancements in cancer therapy and immunology.

Collaborations

During his career, Xiaohui Shao has collaborated with notable colleagues, including Qing Duan and Yuandong Wang. These collaborations have fostered an environment of innovation, enabling them to harness their collective expertise to further advance their research endeavors.

Conclusion

Xiaohui Shao's work exemplifies the spirit of innovation in the medical field. His patents not only contribute to a greater understanding of immunological responses but also pave the way for new treatments that could significantly improve patient outcomes. As he continues to develop novel therapies, Shao remains a key player in the ongoing battle against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…